Masmec has developed advanced surgical navigation systems, AI, and high-complexity medical technologies with application in spinal and trauma procedures.
The clearance expands the VersaLock trauma platform, providing anatomically designed titanium implants featuring ±15° variable-angle locking technology and 3.5 mm dynamic compression.
The study reports the first clinical evidence supporting use of the MolecuLightDX imaging device during revision knee arthroplasty for periprosthetic joint infection.
The sub-component technology, which lets robotics and navigation manufacturers build robots that see what surgeons see, is now ready for partners to integrate.
Developed for physician-led organizations, health systems, and ASC operators, the integrated platform is designed to simplify ASC development, accelerate facility readiness, and support long-term operational success.
The milestone comes within 100 days of its first commercial U.S. procedure, reflecting early surgeon adoption of a motion-preserving alternative to traditional fusion.
Funds will accelerate U.S. commercialization of FDA-cleared SurgiTwin 3D and complete development work on SurgiTwin 4D orthopedic surgical planning software.